Joel Greenblatt’s Clearmind Medicine CMND Stock Holding History

Joel Greenblatt’s Portfolio CMND Stock Details CMND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-861	Closed	-$5.3M	–	1709
2025 Q2	$5.3M	Buy	861 +2	+0.2%	+$769	0.03%	648
2025 Q1	$5.19M	Buy	859 +2	+0.2%	+$1.04K	0.04%	517
2024 Q4	$5.12M	Buy	857 +9	+1%	+$4.99K	0.05%	503
2024 Q3	$5.05M	Buy	+848	New	+$483K	0.05%	486

Other funds holding CMND

AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return

Joel Greenblatt's CMND Position: Q3 2025 in Review

Joel Greenblatt sold out of Clearmind Medicine (CMND) in Q3 2025, closing a stake of 861 shares — an estimated $5.3M sold.

Joel Greenblatt first reported a position in CMND in Q3 2024 and held it in 4 quarters. The position peaked at $5.3M in Q2 2025. 7 funds tracked by Wall St. Rank hold CMND as of Q3 2025.

Joel Greenblatt reported no remaining Clearmind Medicine position as of Q3 2025 after selling out during the quarter.
Joel Greenblatt sold 861 Clearmind Medicine shares in Q3 2025, an estimated $5.3M.
Joel Greenblatt first reported a position in Clearmind Medicine in Q3 2024 and held it in 4 quarters.
Joel Greenblatt's Clearmind Medicine position peaked at $5.3M in Q2 2025.
7 funds tracked by Wall St. Rank held Clearmind Medicine as of Q3 2025.

Based on Gotham Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.